CONMED CORPORATION Lease Obligation Incurred
CONMED CORPORATION (CNMD) reported Lease Obligation Incurred of $200.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2021-02-22.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalLeaseObligationsIncurred · last filed 2021-02-22
- CONMED CORPORATION lease obligation incurred for fiscal 2018 was $200.00K, a 75.00% decline from fiscal 2017.
- CONMED CORPORATION lease obligation incurred for fiscal 2017 was $800.00K.
| Period end | Lease Obligation Incurred 12 month | Lease Obligation Incurred 12 month as first filed |
|---|---|---|
| 2018-12-31 | $200.00K 10-K · filed 2021-02-22 | |
| 2017-12-31 | $800.00K 10-K · filed 2019-02-25 | $762.00K 10-K · filed 2018-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |